Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Speculative Biotech Trades In The Economic Downturn
Seeking Alpha
Monday, June 4, 2012 - 11:49am
tags:
Merck, GSK, XenoPort, Taltorvic, soft tissue sarcomas, Ariad Pharmaceuticals, Horizant, postherpetic neuralgia
Why Comments By Novartis VP Will Send Zalicus' Share Price Up
Seeking Alpha
Monday, June 4, 2012 - 11:12am
tags:
Zalicus, Novartis
ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates
TheStreet.com
Monday, June 4, 2012 - 10:58am
tags:
ASCO, Ariad Pharma, leukemia, Ponatinib
Positive Data for Sanofi's Aubagio
Yahoo/Zacks.com
Monday, June 4, 2012 - 10:56am
tags:
Sanofi, Aubagio, Genzyme, multiple sclerosis
Johnson & Johnson, Bristol-Myers' Cancer Drugs Grab Spotlight
Minyanville
Monday, June 4, 2012 - 10:54am
tags:
JNJ, Bristol-Myers Squibb, ASCO, Zytiga, anti-PD-1 immunotherapy
Bad Romance: Glaxo's Brutal Courtship of Human Genome Sciences
TheStreet.com
Monday, June 4, 2012 - 10:53am
tags:
GSK, M&A, Human Genome Sciences
Frost's Teva investment no vote of confidence
Globes, Israel
Sunday, June 3, 2012 - 1:48pm
tags:
Teva Pharmaceuticals
Is Sun Pharma getting back on the acquisition track?
Live Mint
Sunday, June 3, 2012 - 1:47pm
tags:
Sun Pharma, M&A
Teva’s Treanda Delays Tumor Growth
BusinessWeek
Sunday, June 3, 2012 - 1:46pm
tags:
Teva Pharmaceuticals, Treanda, mantle cell lymphoma, lymphoma
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sunday, June 3, 2012 - 1:45pm
tags:
AstraZeneca, Amylin, M&A
CytRx Announces Favorable Results from Phase 1b/2 Clinical Trial with INNO-206
Yahoo/Business Wire
Sunday, June 3, 2012 - 12:42pm
tags:
CytRx, INNO-206, cancer
Advaxis to Report Updated Safety, Tumor Response, and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer at ASCO
Yahoo/Business Wire
Sunday, June 3, 2012 - 12:41pm
tags:
Advaxis, cervical cancer, ADXS-HPV
3 Reasons To Consider Eli Lilly
Seeking Alpha
Sunday, June 3, 2012 - 12:40pm
tags:
Eli Lilly
ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)
The Street
Sunday, June 3, 2012 - 12:40pm
tags:
colon cancer, Roche, Keryx, perifosine, Avastin
Tris Pharma receives US FDA approval for generic Delsym
Pharmabiz
Sunday, June 3, 2012 - 12:38pm
tags:
Tris Pharma, Delsym, generics
Kowa Pharma, Eli Lilly PREVAIL US study of Livalo met primary endpoint of LDL-C reduction
Pharmabiz
Sunday, June 3, 2012 - 12:35pm
tags:
Eli Lilly, Livalo, hypercholesterolemia, LDL cholesterol
PharmaNAC may be an effective therapy for some features of autism
news-medical.net
Sunday, June 3, 2012 - 12:28pm
tags:
PharmaNAC, autism
Merck Looks to Startups
Technology Review
Sunday, June 3, 2012 - 12:24pm
tags:
Merck
BioMarin Prices Share Offering - Analyst Blog
NASDAQ
Sunday, June 3, 2012 - 12:24pm
tags:
Biomarin
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sunday, June 3, 2012 - 12:23pm
tags:
Bristol-Myers Squibb, AstraZeneca, Amylin, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.